FDA Approves Generic Topical Solution for Scalp Psoriasis

01/02/2018

The FDA has approved a generic topical solution for the treatment of chronic, moderately severe psoriasis of the scalp.

Calcipotriene Topical Solution, 0.005% (Scalp Solution; Lupin Pharmaceuticals) is a generic equivalent to Leo Pharmaceutical’s Dovonex Scalp Solution, 0.005%.

Julie Gould

Reference:

Lupin Pharmaceuticals. Lupin receives FDA approval for generic Dovonex Scalp Solution [press release]. http://www.lupin.com/lupin-receives-fda-approval-for-generic-dovonex-scalp-solution.php. Published December 28, 2017. Accessed January 1, 2018.